Ceramide analog [


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 11 2020
Historique:
received: 18 06 2020
accepted: 22 10 2020
entrez: 10 11 2020
pubmed: 11 11 2020
medline: 1 5 2021
Statut: epublish

Résumé

The metabolism of ceramides is deregulated in the brain of Alzheimer's disease (AD) patients and is associated with apolipoprotein (APO) APOE4 and amyloid-β pathology. However, how the ceramide metabolism changes over time in AD, in vivo, remains unknown. Distribution and metabolism of [

Identifiants

pubmed: 33168861
doi: 10.1038/s41598-020-76335-4
pii: 10.1038/s41598-020-76335-4
pmc: PMC7652882
doi:

Substances chimiques

Amides 0
Apolipoprotein E3 0
Apolipoprotein E4 0
Ceramides 0
Fluorine Radioisotopes 0
N-(3-hydroxy-1-hydroxymethyl-3-phenylpropyl)dodecanamide 0
Sphingolipids 0
Sphingomyelins 0
Fluorine-18 GZ5I74KB8G

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

19354

Subventions

Organisme : VA
ID : VA I01BX003643
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG064234
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG064234
Pays : United States
Organisme : NIH HHS
ID : R01AG034389
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS095215
Pays : United States

Références

J Biol Chem. 2012 Jun 15;287(25):21384-95
pubmed: 22532571
Neurobiol Aging. 2009 Apr;30(4):591-9
pubmed: 17888544
Neurochem Res. 2007 Apr-May;32(4-5):845-56
pubmed: 17342407
PLoS One. 2014 Mar 18;9(3):e92142
pubmed: 24642596
J Neurochem. 2010 Jun;113(6):1369-86
pubmed: 20236389
PLoS One. 2011;6(7):e21643
pubmed: 21779331
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2070-5
pubmed: 14970312
Nature. 2003 Dec 18;426(6968):803-9
pubmed: 14685229
J Neurochem. 2002 Aug;82(4):809-18
pubmed: 12358786
Am J Pathol. 2000 Mar;156(3):797-805
pubmed: 10702395
J Neuroinflammation. 2019 Feb 25;16(1):48
pubmed: 30803453
Prog Lipid Res. 2012 Oct;51(4):378-93
pubmed: 22835784
Biochim Biophys Acta. 2015 Sep;1852(9):1810-23
pubmed: 26022371
Neurobiol Aging. 2010 Mar;31(3):398-408
pubmed: 18547682
PLoS One. 2015 May 04;10(5):e0125597
pubmed: 25938590
Pharmacol Ther. 2018 May;185:34-49
pubmed: 29127024
J Alzheimers Dis. 2019;67(2):503-513
pubmed: 30584141
Mol Neurodegener. 2013 Oct 22;8:34
pubmed: 24148205
J Biol Chem. 2001 Nov 23;276(47):43994-4002
pubmed: 11546801
Neuropathol Appl Neurobiol. 2004 Dec;30(6):624-34
pubmed: 15541003
Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11364-9
pubmed: 17592126
J Cereb Blood Flow Metab. 2015 Jan;35(1):86-94
pubmed: 25335802
ACS Chem Neurosci. 2017 Feb 15;8(2):347-355
pubmed: 27984697
Neurobiol Aging. 2010 Jan;31(1):17-24
pubmed: 18455839
Chembiochem. 2014 Nov 24;15(17):2522-8
pubmed: 25256104
Ann Neurol. 2002 Oct;52(4):448-57
pubmed: 12325074
J Alzheimers Dis. 2017;60(3):783-794
pubmed: 28922150
Biochim Biophys Acta. 2010 Aug;1801(8):878-86
pubmed: 20452460
J Biol Chem. 2005 Feb 25;280(8):6488-95
pubmed: 15596449
Adv Exp Med Biol. 2010;688:1-23
pubmed: 20919643
J Cell Biol. 2004 Jan 5;164(1):123-31
pubmed: 14709545
Acta Neuropathol Commun. 2020 Jul 6;8(1):100
pubmed: 32631455
Acta Neuropathol Commun. 2020 Apr 28;8(1):60
pubmed: 32345374
J Neuroinflammation. 2014 Jun 19;11:111
pubmed: 24948358
J Parkinsons Dis Alzheimers Dis. 2019;6(1):
pubmed: 32190732
Clin Chem. 1993 Apr;39(4):561-77
pubmed: 8472349
Front Cell Dev Biol. 2019 Aug 16;7:166
pubmed: 31475148
Adv Drug Deliv Rev. 2020 Jan 3;:
pubmed: 31911096
Neurobiol Dis. 2006 Jul;23(1):178-89
pubmed: 16626961
J Neurosci. 2012 Jun 27;32(26):8845-54
pubmed: 22745485
Neuroscience. 2005;135(4):1203-15
pubmed: 16165303
J Alzheimers Dis. 2018;63(2):503-514
pubmed: 29660940
PLoS One. 2014 Feb 03;9(2):e88124
pubmed: 24498430
J Alzheimers Dis Rep. 2017 Nov 16;1(1):169-180
pubmed: 30480236
J Alzheimers Dis. 2012;29(3):537-47
pubmed: 22258513
J Neurosci. 2006 Oct 4;26(40):10129-40
pubmed: 17021169
J Biol Chem. 2012 Apr 27;287(18):14897-911
pubmed: 22396542
Mol Neurodegener. 2015 Mar 05;10:7
pubmed: 25871877
PLoS One. 2013 Nov 18;8(11):e79590
pubmed: 24260258
Synapse. 2006 Feb;59(2):119-21
pubmed: 16320304
J Biol Chem. 2012 Dec 7;287(50):41774-86
pubmed: 23060451
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Neurobiol Aging. 2014 Nov;35(11):2486-2494
pubmed: 24952994
Neurology. 2012 Aug 14;79(7):633-41
pubmed: 22815558

Auteurs

Simone M Crivelli (SM)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Universiteitssingel 50, 6229ER, Maastricht, The Netherlands.
Department of Physiology, University of Kentucky College of Medicine, Lexington, KY, USA.

Daan van Kruining (D)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Universiteitssingel 50, 6229ER, Maastricht, The Netherlands.

Qian Luo (Q)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Universiteitssingel 50, 6229ER, Maastricht, The Netherlands.

Jo A A Stevens (JAA)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Universiteitssingel 50, 6229ER, Maastricht, The Netherlands.

Caterina Giovagnoni (C)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Universiteitssingel 50, 6229ER, Maastricht, The Netherlands.

Andreas Paulus (A)

NUTRIM, School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
Department of Nuclear Medicine and Radiology, MUMC+, Maastricht, The Netherlands.
Division of Nuclear Medicine, Uniklinikum Aachen, Aachen, Germany.

Matthias Bauwens (M)

NUTRIM, School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
Department of Nuclear Medicine and Radiology, MUMC+, Maastricht, The Netherlands.

Dusan Berkes (D)

Department of Organic Chemistry, Slovak University of Technology, Radlinského 9, 81237, Bratislava, Slovak Republic.

Helga E de Vries (HE)

Department of Molecular Cell Biology and Immunology, Amsterdam Neuroscience, Amsterdam UMC, Amsterdam, The Netherlands.

Monique T Mulder (MT)

Department of Internal Medicine, Laboratory Vascular Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Jochen Walter (J)

Department of Neurology, University Hospital Bonn, University of Bonn, Bonn, Germany.

Etienne Waelkens (E)

Laboratory of Protein Phosphorylation and Proteomics, KU Leuven, Leuven, Belgium.

Rita Derua (R)

Laboratory of Protein Phosphorylation and Proteomics, KU Leuven, Leuven, Belgium.

Johannes V Swinnen (JV)

Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, Belgium.

Jonas Dehairs (J)

Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, Belgium.

Felix M Mottaghy (FM)

NUTRIM, School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
Department of Nuclear Medicine and Radiology, MUMC+, Maastricht, The Netherlands.
Division of Nuclear Medicine, Uniklinikum Aachen, Aachen, Germany.

Mario Losen (M)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Universiteitssingel 50, 6229ER, Maastricht, The Netherlands.

Erhard Bieberich (E)

Department of Physiology, University of Kentucky College of Medicine, Lexington, KY, USA.
Veterans Affairs Medical Center, Lexington, KY, 40502, USA.

Pilar Martinez-Martinez (P)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Universiteitssingel 50, 6229ER, Maastricht, The Netherlands. p.martinez@maastrichtuniversity.nl.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH